Cite
MLA Citation
P. Helliwell et al.. “FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR).” Annals of the rheumatic diseases, vol. 79, n.d., pp. 765–766. http://access.bl.uk/ark:/81055/vdc_100144729544.0x000040